Scalp eczema and psoriasis may both cause a dry, itchy rash on the scalp. However, several factors differentiate the two, including the rash appearance, level of itchiness, and causes. A clinical ...

Icotrokinra, also known as JNJ-77242113, is an oral interleukin (IL)-23 receptor antagonist that is being evaluated for moderate to severe psoriasis in phase 3 trials. “One caveat,” Strober ...

Bimzelx was approved for the treatment of moderate or severe plaque psoriasis ... if it’s OK to use deodorant or antiperspirant. Scalp psoriasis is a common skin disorder.

A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.

Please provide your email address to receive an email when new articles are posted on . The proportion of deucravacitinib-treated patients that reported no quality-of-life impact increased from 0% ...

Betamethasone foam has superior efficacy for scalp psoriasis and is preferred ... over 100 years and is a key treatment for moderate-to-severe psoriasis. Both ultraviolet A (UVA) and ultraviolet ...

A 28-week study evaluated the real-world effectiveness of tildrakizumab, an anti–IL-23 biologic approved for patients with moderate to severe psoriasis ... patients with scalp and nail ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque psoriasis, Artax Biopharma announced in a press release.

Otezla also led to significant reductions in secondary measures like whole body itch and scalp PGA compared ... top-line results in moderate to severe genital psoriasis, which affects around ...